Don't Miss This VERY Special Black Friday Offer
Trump: Anything Signed by Biden's Autopen Is Hereby Revoked
Is This the Greatest Trump Post of All Time?
Here's What Happened to the DOJ Worker Who Doxxed an ICE Agent
CNN's Top Legal Analyst Explains Why the Georgia Case Got Tossed. Libs Won't...
Watch Trump Totally Cook This Reporter Over This Stupid Question
Trump Announces Major Move to Prevent Future Terrorist Attacks
Appeals Court Rules Against Donald Trump and Alina Habba, Upholds $1 Million Judgment...
Guess What This IL College Will Do to Students Who Follow Federal Law
Aftyn Behn's Anti-Law Enforcement Rhetoric Goes Far Beyond Defunding the Police
The American Soup Kitchen Is Officially Closed
Boston Mayor Says She Isn’t 'Interested in a Bromance With the Federal Regime'
Woman Linked to Karoline Leavitt’s Family Taken Into ICE Custody
Heartland America: After the Collapse of Democrat’s EV Socialism, Bipartisan Protectionism...
California Man Arraigned for Making Bomb Threats to Synagogues
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement